Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from MarketBeat

NVIDIA’s $20B Groq Deal Is a Warning Shot to AI Rivals

NVIDIA fortified its long-term competitive moat by acquiring the fastest chip technology available to dominate the next phase of artificial intelligence growth.

You Don’t Need Big Money for These 3 Under-$30 Stock Plays

You Don’t Need Big Money for These 3 Under-$30 Stock Plays

Looking for affordable stocks with upside? These three stocks under $30 per share offer growth potential in gaming, fintech, and travel

These 3 Household Names Are Flashing Rare Oversold Signals

These 3 Household Names Are Flashing Rare Oversold Signals

Nike, AutoZone, and Costco are all oversold stocks into year-end. But stablizing momentum and analyst support suggests a potential rebound in the weeks ahead.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Eli Lilly’s New Drug Data Sets Up a High-Stakes 2026

Eli Lilly has been a huge winner in the last few months of 2025. New clinical data support its outlook in 2026, with large potential catalysts on the horizon.

3 Stocks at 52-Week Lows With Way More Upside Than Downside

These three stocks are trading near 52-week lows but show improving fundamentals, attractive valuations, and breakout potential for 2026 investors

4 Reasons Colgate-Palmolive Is a No-Brainer Hold Through 2027

Colgate-Palmolive is a good buy-and-hold stock for 2026, as it is on the cusp of a significant market reversal linked to value and capital returns.

Amid Tech Volatility, These 3 Stocks Are Up & Boosting Buybacks

With talk of an "AI bubble" increasing, investors are piling into non-tech stocks like WM, RCL, and BCO. These names also just announced large buyback boosts.

inkl

Read news from The Economist, FT, and more,
with one subscription

Sector Rotation: 2 Smart Money Moves for 2026

Sector Rotation: 2 Smart Money Moves for 2026

Investors are rotating capital into communication services and healthcare stocks as falling interest rates create new opportunities for growth and income.

Why Kratos and AeroVironment Are Suddenly Moving Like Tech Stocks

Why Kratos and AeroVironment Are Suddenly Moving Like Tech Stocks

Kratos and AeroVironment are actively transforming the defense sector by shifting from legacy industrial models to high-growth technology platforms.

Microsoft May Look Pricey, But Customers Can’t Walk Away

Microsoft May Look Pricey, But Customers Can’t Walk Away

Microsoft stock looks pricey, but high switching costs, enterprise lock-in, and AI integration may justify the premium for long-term investors

Oil’s Outlook Looks Ugly—That’s Why These 3 Energy Plays Matter

Oil’s Outlook Looks Ugly—That’s Why These 3 Energy Plays Matter

With energy sector stocks trailing the broader market amid depressed oil prices, investors with patience and risk tolerance may find opportunities here.

This ETF Will Benefit From Americans' Higher Energy Bills

This ETF Will Benefit From Americans' Higher Energy Bills

Electric bills are up 13% since President Trump took office. That’s bad news for the average American but good news for utilities investors.

From Lagging to Leading: FuelCell Energy’s Strategic Pivot

From Lagging to Leading: FuelCell Energy’s Strategic Pivot

FuelCell Energy stock rallied on strong revenue growth and a strategic shift toward providing reliable power for artificial intelligence data centers.

Paychex Is Out of Favor—And That’s the Opportunity

Paychex Is Out of Favor—And That’s the Opportunity

Paychex's stock price is at rock bottom, presenting a high-yield opportunity for investors in 2026. Catalysts lie ahead that may trigger a robust rebound.

Get all your
news in one place.

100’s of premium titles.
One news app.

Beer’s Big Comeback? 2 Stocks Poised to Benefit in 2026

Major global events could spark a beer demand rebound in 2026. See why Constellation Brands and Molson Coors may benefit from the shift

Forget The Chips: Oracle Wins Phase 2 of AI

Strategic wins in data center expansion and sovereign cloud partnerships are redefining Oracle as the indispensable utility provider powering the AI economy.

3 Mining Companies to Fill Stockings With More Than Just Coal

With gold and other metals at record highs, these mining companies have already soared this year. Here are some that could continue to rally in 2026.

Lululemon Is a Good Fit for 2026: Limited Downside, Ample Upside

Lululemon's stock price is on track to rebound in 2026, potentially rising as much as 80% as the market buys into a CEO change and international growth.

Get all your
news in one place.

100’s of premium titles.
One news app.

Sidus Space Breaks Into the $151B Golden Dome Defense Buildout

Sidus Space surged after securing a spot on a massive missile defense contract, validating its satellite technology for the new Golden Dome strategy.

Vertical Aerospace Traded a Delay for a Major Advantage

Vertical Aerospace doubles testing capacity with a new prototype aircraft while securing vital regulatory approvals to accelerate its certification path.

Alphabet’s Pullback After a Big Year—Is This the Dip to Buy?

GOOGL has pulled back after a standout year, but strong fundamentals and a healthy technical setup suggest the long-term uptrend remains firmly intact.

Darden Restaurants, Inc.: This is What a Strong Signal Looks Like

Darden Restaurants is positioned for market-beating total returns in 2026 as a technical signal combines with fundamental qualities like dividends and buybacks.

Amazon Looks Stuck—So Why Do Analysts Keep Calling for $300?

Amazon stock is stuck in consolidation mode despite multiple $300-plus targets. But tightening price action suggests a breakout might be coming.

Carnival’s Dividend Return Marks the End of Survival Mode

Carnival Corporation has reinstated its dividend following a record year of financial recovery and debt reduction.

Why CorMedix Could be the Biopharma Name to Watch Early in 2026

CorMedix is a promising biopharma firm in the catheter lock solution space. Continued success for its top products could fuel significant growth into 2026.

1 … 17 18 19 20

People

166,855 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

340,691 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play